The human body recognises bioelectronic implants as “foreign” and launches immune cells against them. This inflammatory response leads to fibrotic (scar) tissue growth around the implant. Researchers have incorporated compounds with known immunomodulating properties into a semiconducting polymer often used for research on implantable bioelectronics, to see if they could improve its immune compatibility.